Free Trial

MultiPlan (MPLN) Projected to Post Quarterly Earnings on Tuesday

MultiPlan logo with Medical background

MultiPlan (NYSE:MPLN - Get Free Report) will likely be posting its quarterly earnings results before the market opens on Tuesday, February 25th. Analysts expect MultiPlan to post earnings of ($13.50) per share and revenue of $234.77 million for the quarter. Individual that are interested in participating in the company's earnings conference call can do so using this link.

MultiPlan Stock Down 0.5 %

MultiPlan stock traded down $0.15 during midday trading on Friday, hitting $29.32. The company's stock had a trading volume of 173,187 shares, compared to its average volume of 165,208. The company has a debt-to-equity ratio of 21.73, a current ratio of 1.05 and a quick ratio of 1.05. The business's 50-day simple moving average is $16.94. MultiPlan has a 12 month low of $4.80 and a 12 month high of $48.80. The firm has a market capitalization of $474.15 million, a P/E ratio of -0.31 and a beta of 0.13.

Wall Street Analyst Weigh In

Separately, Citigroup boosted their price target on shares of MultiPlan from $10.00 to $12.50 and gave the stock a "neutral" rating in a research report on Friday, January 10th.

Read Our Latest Report on MultiPlan

MultiPlan Company Profile

(Get Free Report)

MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services.

See Also

Earnings History for MultiPlan (NYSE:MPLN)

Should You Invest $1,000 in MultiPlan Right Now?

Before you consider MultiPlan, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MultiPlan wasn't on the list.

While MultiPlan currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines